KULEA-NET: A Mobile Application for African American/Black Mothers to Promote Exclusive and Continuous Breastfeeding
KULEA-NET
Knowledge and Usage of Lactation Using Education and Advice From Support Network (KULEA-NET)
2 other identifiers
interventional
523
1 country
3
Brief Summary
KULEA-NET is a mHealth intervention that will improve knowledge, self-efficacy, and intentions related to exclusive breastfeeding (EBF). These factors have been demonstrated to have a positive influence on breastfeeding (BF) initiation and duration among African American/Black (AA/B) mothers. In the long term, KULEA-NET has great potential to achieve increased BF initiation and EBF rates among AA/B mothers and as a result, improved maternal and infant health outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Nov 2023
Shorter than P25 for phase_2
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 6, 2023
CompletedFirst Posted
Study publicly available on registry
August 14, 2023
CompletedStudy Start
First participant enrolled
November 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2024
CompletedAugust 14, 2023
August 1, 2023
6 months
July 6, 2023
August 3, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Change of exclusive breastfeeding (EBF) rates
We will assess if participants are breastfeeding exclusively through self-reported information and corroborate with data entered in the feeding and diaper logs. We will record information on EBF at 4 weeks, and 24 weeks follow-up among women in the intervention arm #1. We will record information on EBF at 4 weeks, and 24 weeks follow-up among women in the intervention arm #2. We will record information on EBF at baseline, 4 weeks, and 24 weeks follow-up among women in the intervention arm #3.
Baseline, week 4 postpartum follow-up and week 24 postpartum follow-up
Secondary Outcomes (2)
Change of any breastfeeding (BF) rates
Baseline, week 4 postpartum follow-up and week 24 postpartum follow-up
Change of breastfeeding initiation rates
Baseline, week 4 postpartum follow-up and week 24 postpartum follow-up
Other Outcomes (7)
Change of breastfeeding attitudes
Baseline, week 4 postpartum follow-up and week 24 postpartum follow-up
Change of intention to breastfeed
Baseline, week 4 postpartum follow-up and week 24 postpartum follow-up
Change of breastfeeding self-efficacy
Baseline, week 4 postpartum follow-up and week 24 postpartum follow-up
- +4 more other outcomes
Study Arms (2)
KULEA-NET application
EXPERIMENTALParticipants using the KULEA-NET application in addition to the usual care
Control Group: Usual Care
EXPERIMENTALControl participants will receive usual care i.e. standard obstetrical care at MWHC and Mamatoto Village and will receive the standard Babyscripts app only without the KULEA-NET tile.
Interventions
African American/Black (AA/B) women recruited at 3 distinct stages of pregnancy - i.e. 1) 29 to 34 weeks gestational age, 2) 35 to 40 weeks gestational age, and 3)immediately post-partum, will be assigned to the intervention group and start using the KULEA-NET platform. Women in the intervention arm #1 will use KULEA-NET for a total duration of approximately 9 months (3 months prenatal and 6 months post-partum; women in the intervention arm #2 will use KULEA-NET for a total duration of approximately 7 months (1 month prenatal and 6 months post-partum); and women in the intervention arm #3 will use KULEA-NET for a total duration of approximately 6 months (only post-partum). Each woman will have access to all components of the KULEA-NET platform: the text messages, knowledge base, 3 different types of videos, and breastfeeding-friendly spaces and breastfeeding classes near them.
Control participants will receive usual care i.e. standard obstetrical care at MWHC and Mamatoto Village and will receive standard Babyscripts app only without the KULEA-NET tile. Information from the ACOG about the maternal and infant health benefits of breastfeeding will also be provided (e.g., they will get pamphlets on the importance of breastfeeding as well as lactation consultation).
Eligibility Criteria
You may qualify if:
- African American/Black Ethnicity
- Speak and understand English,
- Between the ages of 18-44 years,
- Intention to continue BF after discharge from the hospital
- Willingly provide written informed consent
- Own a smartphone (either iOS or Android)
- Have access to the internet through their smartphone
You may not qualify if:
- An infant born with cleft lip/palate, congenital heart defects, Down Syndrome, neural tube defects, or other conditions that require admission to a NICU or interfere with BF
- Human immunodeficiency virus (HIV)
- Taking antiretroviral medication or chemotherapy agents
- Untreated, active tuberculosis
- T-Cell lymphotropic virus type I or type II
- Illicit drug use
- Receiving radiation therapy
- Exposed to anthrax
- Undergone breast surgery
- Active hepatitis B or C
- Any prescription drug use incompatible with lactation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Benten Technologies, Inc.lead
- George Washington Universitycollaborator
- Medstar Health Research Institutecollaborator
- National Institute on Minority Health and Health Disparities (NIMHD)collaborator
Study Sites (3)
Mamatoto Village
Washington D.C., District of Columbia, 20019-3739, United States
The George Washington University
Washington D.C., District of Columbia, 20052-0042, United States
Medstar Health Research Institute
Hyattsville, Maryland, 20782, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tony Ma, MS
Benten Technologies
- PRINCIPAL INVESTIGATOR
Doug Evans, PhD
George Washington University
- PRINCIPAL INVESTIGATOR
Loral Patchen, PhD
Medstar Research Health Institute
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Project Director or Principal Investigator
Study Record Dates
First Submitted
July 6, 2023
First Posted
August 14, 2023
Study Start
November 1, 2023
Primary Completion
April 30, 2024
Study Completion
May 30, 2024
Last Updated
August 14, 2023
Record last verified: 2023-08